Dysregulation of Neurotrophic and Haematopoietic Growth Factors in Alzheimer’s Disease: From Pathophysiology to Novel Treatment Strategies
Year: 2014
Type: article
Abstract: Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Growth factors have been demonstrated to act in a synergistic way in angiogenesis and neurogenesis contributing to self-healing powers of the adult human brain. A growing body of evidence demonstrates that levels of many growth factors (neurotrophins and hematopoietins) are altered in cerebrospinal fluid and peripheral blood from AD patients and in animal models of AD. The present review summarizes the role of several neurotrophic growth factors (e.g., BDNF, SCF, NGF, GDNF) and haematopoietic growth factors (e.g., G-CSF, VEGF, SDF-1) in AD. Moreover, we summarize recent studies evaluating the diagnostic and prognostic value of growth factor levels in blood and cerebrospinal fluid in patients with AD and discuss the potential role of these growth factors as a promising new therapeutic approach in AD.
Source: Current Alzheimer Research
Authors: Kateryna Sopova, Katerina Gatsiou, Konstantinos Stellos, Christoph Laske
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, neurotrophic factors, hematopoietic growth factors, brain-derived neurotrophic factor, nerve growth factor, glial cell line-derived neurotrophic factor, stem cell factor, granulocyte colony-stimulating factor, vascular endothelial growth factor, CXCL12, cerebrospinal fluid biomarkers, blood biomarkers, angiogenesis, neurogenesis, therapeutic target, diagnosis and prognosis
Open Access status: green
OpenAlex ID: W2112233227
